Added to YB: 2025-04-03
Pitch date: 2025-04-02
ENZ [bullish]
Enzo Biochem, Inc.
+111.78%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.
Market Cap
$35.7M
Pitch Price
$0.33
Price Target
1.60 (+129%)
Dividend
14.68%
EV/EBITDA
-0.21
P/E
-4.53
EV/Sales
0.07
Sector
Life Sciences Tools and Services
Category
value
Enzo Biochem (ENZ): Undervalued with Key Catalysts Like Asset Sales & NOLs
ENZ: $16M mkt cap vs $32M NCAV, $40M cash, $15M real estate, $15M NOLs, $30M rev opco. $1.60/sh value vs $0.32 price. Risks: lawsuits, value erosion. Potential catalysts: asset sales, NOL monetization. Moving OTC. Recent board appointee experienced in NOL deals.
Read full article (2 min)